KFFs 2025 employer survey found 18% of large employers explicitly excluded obesity-indication GLP-1s, while another 22% required prior authorization with BMI and behavioral-program documentation
159 As of now, GLP-1-related triple agonists are primarily still in the development stage and have not been widely approved for use
Provider review A licensed medical provider reviews your intake and determines what's right for you
Earlier assessment may provide more options for managing hair loss
David Hunter, MD, an associate professor of neurology at UTHealth Houston, not involved in this review, spoke with Medical News Today about its findings
Heres why clients trust us: Expert Practitioners : Certified providers with extensive weight management experience Personalized Approach : Tailored programs for balanced results Safe & Comfortable : Our facility meets the highest medical standards Exceptional Care : We prioritize your success and confidence We believe medical treatments should enhancenot compromiseyour well-being